[ad_1]
The German biotech company with the American pharmaceutical company Pfizer has developed the biontech partners ‘bnt162ö’ from a possible new type of coronavirus vaccine (Kovid-19), tested on 1000 volunteers who were also reported to be in Turkey .
According to the news from T24, Phase 1 and 2 studies were determined, and the vaccine was successfully tested in 7 thousand people working for the 9 centers in Turkey. It is indicated that vaccination will begin on September 10, It was said that studies are expected to be completed by the end of the month and that the vaccine will be launched on the market.
Ankara University School of Medicine, Department of Infectious Diseases from the letter sent to the dean’s office, stated that the Phase 3 study is the first study vaccine to be carried out in Turkey, “We are excited to take on a historic mission” It was said.
It is stated that the potential vaccine, which is said to be tested in a total of 30,000 people from 172 countries, is considered the best among the candidates, and that the acceptance and voluntary approval will be immediate and the study of the vaccine will begin on the 10th. September 2020.
The following statements were included in the letter sent to the Dean’s Office:
“A German-sourced biotech authorization (BioNTech) developed a curation, production and marketing partnership with Pfizer for the Sars-CoV 2 (Covid-19) vaccine. Phase 3 study support was selected for the EE. In the US, Germany and Turkey. Our faculty Department of Infectious Diseases 9 centers in Turkey were also selected in the branch. In our country, the study of the Ministry of Health to be conducted on about 1,000 volunteers and the approval of the Committee of Ethics is complete, voluntary acceptance and registrations will begin immediately and vaccination studies will begin on September 10, 2020. Vaccination with other countries will be completed at the end of September and will be released later.
The world hopes to have the Covid vaccine as soon as possible, and the process of recruiting and vaccinating volunteers should be completed very quickly. For this reason, we need to make this study announcement on our web pages of the University and Faculty of Medicine (the protocol only allows the announcement in this way and / or with posters, brochures) and finalize the recruitment of volunteers before the vaccine arrives. . Volunteer applications will be accepted, including our teaching and university staff and their families. Half of the volunteers will not be vaccinated, like the blind controlled Plesebo study.
This mRNA vaccine, the Covidien vaccine to be accepted as the best of the candidates and to undertake a task we carry the emotion of history because it is the first Phase 3 study vaccine administered to Turkey to this day. Bidders must apply to the Department of Infectious Diseases and Clinical Microbiology. “
[ad_2]
